HappeningToo topic
Everolimus reports
Browse community reports connected to Everolimus. These reports can show that other people are describing similar experiences, but they do not prove that Everolimus caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
37 problems
Abdominal Discomfort while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and abdominal discomfort appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and abdominal distension appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and abdominal pain upper appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and abdominal pain appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acne while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and acne appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and alopecia appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and anxiety appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and back pain appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and chills appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and constipation appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and cough appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and decreased appetite appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and dehydration appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and diarrhea appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and dizziness appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and dry skin appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and fatigue appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and feeling abnormal appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and headache appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and hypotension appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and insomnia appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and itching appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and malaise appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Mouth Ulceration while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and mouth ulceration appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and myalgia appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and nausea appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and oropharyngeal pain appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and pain appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and peripheral swelling appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and rash appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and shortness of breath appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and skin redness appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and swelling appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Taste changes while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and taste changes appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and vomiting appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and weakness appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Everolimus
FDA FAERS contains adverse-event reports in which Everolimus and weight decreased appear together. This does not establish that Everolimus caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →